Pogue Mahone
The caf's Camus.
Good-ish news.
The SA variant caused sixfold reductions in antibody titres. They reckon this is still high enough to provide immunity overall but that’s still a big reduction. There’s a good chance it will reduce duration of protection and could make it completely ineffective in a minority of people who don’t respond well to the vaccine.
I’m sure all the companies producing vaccines (especially mRNA vaccines) are getting cracking on tweaking their product to work better against this variant. Sounds like they need to.